EMPULSE (Completed)
a Phase III trial to evaluate the effect on changes in NT-proBNP, safety and tolerability of once daily oral EMPaglilozin 10 mg compared to placebo, initiated in patients hospitalized for acUte decompensated heart faiLure who have been StabilizEd (EMPULSE)
- Medicine
- Empagliflozine
- Population
- Heart failure
- Phase
- III
- Starting year
- 2019
- More information
- Clinicaltrials.gov